We have bad news and good news about patent expiration next year. The bad? When you total up the billions of sales at risk of patent expiration in 2015, the result is $44 billion, the biggest number since the debacle of 2012. That year, $53 billion worth of drugs fell off patent - and many drugmakers are still reeling.
But in 2015, generics are expecting to take a much smaller bite from the drugs losing exclusive access to their respective markets. That's because several of the big expiries involve biotech drugs...Read the full article here.